[go: up one dir, main page]

CA2415544A1 - Compositions et procedes pour le traitement et le diagnostic du cancer du poumon - Google Patents

Compositions et procedes pour le traitement et le diagnostic du cancer du poumon Download PDF

Info

Publication number
CA2415544A1
CA2415544A1 CA002415544A CA2415544A CA2415544A1 CA 2415544 A1 CA2415544 A1 CA 2415544A1 CA 002415544 A CA002415544 A CA 002415544A CA 2415544 A CA2415544 A CA 2415544A CA 2415544 A1 CA2415544 A1 CA 2415544A1
Authority
CA
Canada
Prior art keywords
seq
clone
cdna sequence
determined cdna
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002415544A
Other languages
English (en)
Inventor
Tongtong Wang
Yoshihiro Watanabe
Robert A. Henderson
Jeffrey C. Johnson
Marc W. Retter
Margarita Durham
Darrick Carter
Gary Richard Fanger
Thomas S. Vedvick
Chaitanya S. Bangur
Andria Mcnabb
Aijun Wang
Neil Fanger
Ann Switzer
Patricia D. Mcneill
Jonathan D. Clapper
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Corixa Corp
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/614,124 external-priority patent/US6630574B1/en
Priority claimed from US09/651,563 external-priority patent/US6914132B1/en
Priority claimed from US09/658,824 external-priority patent/US6746846B1/en
Priority claimed from US09/671,325 external-priority patent/US6667154B1/en
Priority claimed from US09/702,705 external-priority patent/US6504010B1/en
Priority claimed from US09/736,457 external-priority patent/US6509448B2/en
Priority claimed from US09/849,626 external-priority patent/US20020197669A1/en
Application filed by Individual filed Critical Individual
Publication of CA2415544A1 publication Critical patent/CA2415544A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A61K40/11—T-cells, e.g. tumour infiltrating lymphocytes [TIL] or regulatory T [Treg] cells; Lymphokine-activated killer [LAK] cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/20—Cellular immunotherapy characterised by the effect or the function of the cells
    • A61K40/24—Antigen-presenting cells [APC]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/41—Vertebrate antigens
    • A61K40/42—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

L'invention concerne des compositions et des procédés pour le traitement et le diagnostic du cancer, en particulier du cancer du poumon. Les compositions typiques comprennent un ou plusieurs polypeptides de tumeur pulmonaire, des parties immunogènes de ceux-ci, des polynucléotides qui codent pour ces polypeptides, une cellules présentatrice d'antigène qui exprime ces polypeptides, et des lymphocytes T spécifiques de cellules exprimant ces polypeptides. Les compositions décrites sont utiles, par exemple, dans le diagnostic, la prévention et/ou le traitement de maladies, en particulier le cancer du poumon.
CA002415544A 2000-07-11 2001-07-10 Compositions et procedes pour le traitement et le diagnostic du cancer du poumon Abandoned CA2415544A1 (fr)

Applications Claiming Priority (17)

Application Number Priority Date Filing Date Title
US09/614,124 US6630574B1 (en) 1999-06-30 2000-07-11 Compositions and methods for the therapy and diagnosis of lung cancer
US09/614,124 2000-07-11
US09/651,563 US6914132B1 (en) 1999-06-30 2000-08-29 Compositions and methods for the therapy and diagnosis of lung cancer
US09/651,563 2000-08-29
US09/658,824 US6746846B1 (en) 1999-06-30 2000-09-08 Methods for diagnosing lung cancer
US09/658,824 2000-09-08
US09/671,325 2000-09-26
US09/671,325 US6667154B1 (en) 1999-06-30 2000-09-26 Compositions and methods for the therapy and diagnosis of lung cancer
US67741900A 2000-10-06 2000-10-06
US09/677,419 2000-10-06
US09/702,705 US6504010B1 (en) 1999-06-30 2000-10-30 Compositions and methods for the therapy and diagnosis of lung cancer
US09/702,705 2000-10-30
US09/736,457 US6509448B2 (en) 1999-06-30 2000-12-13 Compositions and methods for the therapy and diagnosis of lung cancer
US09/736,457 2000-12-13
US09/849,626 US20020197669A1 (en) 2000-12-13 2001-05-03 Compositions and methods for the therapy and diagnosis of lung cancer
US09/849,626 2001-05-03
PCT/US2001/022058 WO2002004514A2 (fr) 2000-07-11 2001-07-10 Compositions et procedes pour le traitement et le diagnostic du cancer du poumon

Publications (1)

Publication Number Publication Date
CA2415544A1 true CA2415544A1 (fr) 2002-01-17

Family

ID=27575493

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002415544A Abandoned CA2415544A1 (fr) 2000-07-11 2001-07-10 Compositions et procedes pour le traitement et le diagnostic du cancer du poumon

Country Status (6)

Country Link
EP (1) EP1343886A2 (fr)
JP (1) JP2004512824A (fr)
AR (1) AR031250A1 (fr)
AU (1) AU2002218770A1 (fr)
CA (1) CA2415544A1 (fr)
WO (1) WO2002004514A2 (fr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030170255A1 (en) * 1999-06-30 2003-09-11 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US20030211510A1 (en) 1999-06-30 2003-11-13 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US6893818B1 (en) 1999-10-28 2005-05-17 Agensys, Inc. Gene upregulated in cancers of the prostate
JP2004522404A (ja) * 1999-12-01 2004-07-29 ジェネンテック・インコーポレーテッド 分泌及び膜貫通ポリペプチドとそれをコードしている核酸
US20030166300A1 (en) * 2000-08-30 2003-09-04 Tang Y. Tom Growth-related inflammatory and immune response protein
ZA200204907B (en) * 2001-06-26 2003-03-03 Univ Nat Taiwan Collapsin Response Mediator Protein-1.
US20060242721A1 (en) * 2002-08-14 2006-10-26 Sang-Seok Koh Gene families associated with liver cancer
WO2004028447A2 (fr) * 2002-09-26 2004-04-08 Genentech, Inc. Nouvelles compositions et methodes destinees au traitement du psoriasis
TW200413725A (en) * 2002-09-30 2004-08-01 Oncotherapy Science Inc Method for diagnosing non-small cell lung cancers
US7449291B1 (en) 2003-01-13 2008-11-11 University Of Washington Methods for identifying subjects susceptible to Charcot-Marie-Tooth neuropathy type 1C
WO2004070058A1 (fr) * 2003-02-03 2004-08-19 Bayer Healthcare Ag Methodes et compositions permettant de prevoir, diagnostiquer, pronostiquer, prevenir et traiter des broncho-pneumopathies chroniques obstructives
CA2520512A1 (fr) * 2003-03-24 2004-10-07 Corixa Corporation Methodes, compositions et trousses pour la detection et pour la surveillance d'un cancer du poumon
JP4643450B2 (ja) 2003-08-08 2011-03-02 株式会社ペルセウスプロテオミクス 癌高発現遺伝子
WO2005029067A2 (fr) * 2003-09-24 2005-03-31 Oncotherapy Science, Inc. Methode de diagnostic du cancer du sein
JP4428995B2 (ja) 2003-12-03 2010-03-10 関東化学株式会社 金属膜のエッチング液組成物
WO2006131783A2 (fr) * 2004-01-27 2006-12-14 Compugen Usa, Inc. Nouvelles sequences d'aminoacides et de nucleotides, et dosages et methodes d'utilisation afferentes dans le diagnostic du cancer du poumon
US20050186577A1 (en) 2004-02-20 2005-08-25 Yixin Wang Breast cancer prognostics
US8940488B2 (en) 2004-03-31 2015-01-27 Hiroyuki Aburatani Cancer diagnosis and treatment of cancer using anti-robo 1 antibody
WO2005095981A1 (fr) 2004-03-31 2005-10-13 Perseus Proteomics Inc. Diagnostic du cancer et traitement utilisant l’anticorps anti-robo1
WO2007013480A2 (fr) * 2005-07-29 2007-02-01 Oncotherapy Science, Inc. Criblage et methode therapeutique anti-nsclc ciblant le complexe cda1-kntc2
EP2069498A1 (fr) * 2006-12-21 2009-06-17 Intradigm Corporation Compositions inhibitrices de polynucléotide et procédés de traitement du cancer
JP5117765B2 (ja) 2007-05-28 2013-01-16 国立大学法人 東京大学 抗ｒｏｂｏ１抗体を含むｐｅｔ用腫瘍診断剤
DK2186889T3 (en) * 2007-08-20 2015-06-08 Oncotherapy Science Inc CDCA1 PEPTID AND PHARMACEUTICAL COMPOSITION, INCLUDING THIS
TWI526219B (zh) 2008-06-19 2016-03-21 腫瘤療法 科學股份有限公司 Ｃｄｃａ１抗原決定位胜肽及含此胜肽的疫苗
WO2010134601A1 (fr) * 2009-05-22 2010-11-25 国立大学法人岡山大学 Peptide induisant une réponse immunitaire spécifique contre xage-1b et son utilisation
EP2872532A4 (fr) 2012-07-10 2016-04-13 Oncotherapy Science Inc Peptides épitopes du cdca1 pour cellules th1 et vaccins les contenant
TW202023581A (zh) 2018-08-02 2020-07-01 日商腫瘤療法 科學股份有限公司 來自cdca1的胜肽及含有此的疫苗
CN114102955B (zh) * 2020-08-31 2024-05-07 天津科技大学 一种采用常温发泡技术制备发泡聚乳酸的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10139800A (ja) * 1996-11-15 1998-05-26 Santen Pharmaceut Co Ltd シェーグレン症候群治療剤
ID27813A (id) * 1998-01-28 2001-04-26 Corixa Corp Senyawa-senyawa untuk terapi dan diagnosa kanker paru-paru dan metoda untuk penggunaannya
WO2000055375A1 (fr) * 1999-03-17 2000-09-21 Alphagene, Inc. Proteines secretees et polynucleotides les codant
EP1196565A2 (fr) * 1999-06-30 2002-04-17 Corixa Corporation Compositions et techniques de therapie et de diagnostic du cancer du poumon

Also Published As

Publication number Publication date
EP1343886A2 (fr) 2003-09-17
WO2002004514A2 (fr) 2002-01-17
WO2002004514A8 (fr) 2002-12-27
JP2004512824A (ja) 2004-04-30
WO2002004514A3 (fr) 2003-06-19
AU2002218770A1 (en) 2002-01-21
AR031250A1 (es) 2003-09-17

Similar Documents

Publication Publication Date Title
US6858710B2 (en) Compositions and methods for the therapy and diagnosis of ovarian cancer
US7425607B2 (en) Compositions comprising a lung tumor antigen
US6504010B1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
US20080317755A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
CA2415544A1 (fr) Compositions et procedes pour le traitement et le diagnostic du cancer du poumon
CA2412223A1 (fr) Compositions et procedes servant a traiter et a diagnostiquer le cancer du colon
EP1287029A2 (fr) Compositions et procedes pour la therapie et le diagnostic du cancer du colon
US6858204B2 (en) Compositions and methods for the therapy and diagnosis of lung cancer
US6509448B2 (en) Compositions and methods for the therapy and diagnosis of lung cancer
US20020172952A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
US20070292415A1 (en) Compositions and methods for the therapy and diagnosis of breast cancer
WO2002074237A2 (fr) Compositions et procedes de therapie et de diagnostic du cancer du rein
US20020150922A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
US20030170255A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
US7888477B2 (en) Ovarian cancer-associated antibodies and kits
US20020197669A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
US20030069180A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
CA2437564A1 (fr) Compositions et methodes de therapie et de diagnostic du cancer du sein
WO2001096389A2 (fr) Compositions et procedes pour la therapie et le diagnostic du cancer du colon
US20020131971A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
US20110177082A1 (en) Compositions and methods for the therapy and diagnosis of ovarian cancer
US20020156011A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued